SEARCH TEMPLE HEALTH
Lung Center

Temple Lung Center ATS 2022 Schedule

Follow Temple Faculty and Fellows as they present at this year’s conference

May 15-19 | San Francisco, CA

Authorities in the field, including internationally renowned pulmonologist Gerard J. Criner, MD, board member for the Global Initiative for Chronic Obstructive Lung Disease (GOLD), an author of the GOLD guidelines and Director of the Temple Lung Center in Philadelphia, Pennsylvania presented at the following sessions:

Jump to:

Sunday, May 15, 2022

Session A14 - INVESTIGATING COPD HEALTH INEQUITIES

Time: 9:50 AM - 10:00 AM

Race-Based Spirometry Under-Diagnoses COPD in African-American Smokers
E. A. Regan, M. E. Lowe, J. L. Curtis, C. Wilson, R. Casaburi, A. K. Baldomero, A. Balasubramanian, M. C. Mccormack, K. A. Young, G. L. Kinney, G. R. Oates, K. F. Hoth, A. A. Diaz, Q. Chen, V. Kim, B. J. Make, J. K. O'Brien, J. Crooks, G. E. Westney, K. Lowe, N. A. Hanania, S. Watts, D. J. Conrad, H. Amaza, S. P. Bhatt, S. Fortis, A. J. Mamary, N. Putcha, M. G. Foreman, M. T. Dransfield, N. N. Hansel, D. L. Demeo, E. K. Silverman, J. D. Crapo, R. A. Wise, for the COPDGene Investigators


Session A22 - IMAGING AND MOLECULAR BIOMARKERS IN COPD

Time: 9:30 AM - 11:00 AM

101 - Airway Mucus Plugs on CT Scan Are Associated with Worse Patient Reported Outcomes in Smokers with and Without COPD and No History of Exacerbations: A Cross Sectional Analysis of the COPDGene Study
V. Kim, W. R. Dolliver, J. L. Orejas, S. Grumley, A. Yen, S. J. Kligerman, P. P. Manapragada, K. Jacobs, M. Abozeed, M. A. Aziz, M. Zahid, S. Sonavane, N. Terry, A. Ahmed, H. Nath, R. San Jose Estepar, A. A. Diaz, COPDGene Investigators


Session A26 - CUTTING EDGE PEDIATRIC COVID-19 SCIENCE

Time: 9:30 AM - 11:00 AM

116 - COVID-19 Pandemic and Inner City Youth E-Cigarette Use
J. Klein, K. Cohen, A. Fales, T. Pham, H. Choi, B. N. Collins, S. Lepore, J. L. Garfield


Session A45 - TOXICOLOGY, PHARMACOLOGY, AND ENDOCRINOLOGY

Time: 11:15 AM - 1:15 PM

P632 - Simultaneous Plasmapheresis and Veno-Venous ECMO for Acute Stabilization of Hypertriglyceridemia-Pancreatitis
A. Beckman, J. Kim, S. Verga, P. Mulhall


Session A44 - ICU CURRICULUM AND SYSTEMS

Time: 11:15 AM - 1:15 PM

P567 - Intensive Care Unit (ICU) in a Nutshell Curriculum: A Fellow Led Intervention
S. Gayen, V. Dronamraju, N. Van Der Rijst, O. A. O'Corragain, M. Vega Sanchez, E. R. Camac;


Session A54 - BAYVIEW: PULMONARY EMBOLI

Time: 11:15 AM - 1:15 PM

P88 - Pulmonary Embolism Response Team, Outcomes from a Large Tertiary Academic Center
D. C. Fleitas Sosa, O. A. O'Corragain, D. Sacher, V. Lakhter, R. Bashir, G. Cohen, J. Panaro, G. J. Criner, P. Rali

P89 - Clinical Comparison of Black and Caucasian Patients with Pulmonary Embolism in an Urban Underserved Population
V. H. Dronamraju, K. U. Lio, R. Badlani, S. Brosnahan, A. Lehr, P. Rali

P90 - Renal Dysfunction in Acute Pulmonary Embolism: A Poor Prognostic Sign
D. Sacher, O. A. O'Corragain, T. Thakur, R. Badlani, H. Davis, N. Mehta, K. Lio, J. Moore, R. Bashir, V. Lakhter, J. Panaro, G. J. Criner, P. Rali
 
P91 - Sodium Levels in Acute Pulmonary Embolism: Higher May Not Mean Better
D. Sacher, O. A. O'Corragain, T. Thakur, R. Badlani, H. Davis, K. Lio, N. Mehta, J. Moore, R. Bashir, V. Lakhter, J. Panaro, G. J. Criner, P. Rali

P97 - Improvement of Right Ventricular Function After Novel Pharmaco-Mechanical Catheter Directed Thrombolysis with BASHIRTM Endovascular Catheter - A Single Center Experience
C. M. Romero, M. Al-Otaibi, K. Frenchu, M. Singh, J. Panero, P. Rali, V. Lakther, R. Bashir


Session A56 - MISSION: CASE REPORTS IN THROMBOEMBOLIC DISEASE

Time: 11:15 AM - 1:15 PM

P119 - Pre- and Post-Procedure Lung Perfusion Comparison in Patients Treated with Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism (PE)
S. Gayen, V. Upadhyay, S. Dadparvar, M. Kumaran, G. J. Criner, P. Rali


Session A59 - TUBERCULOSIS

Time: 11:15 AM - 1:15 PM

P1008 - Disseminated Tuberculosis Masquerading as a Bladder Tumor
B. H. Lashari, V. Dronamraju, T. Thakur, P. B. Desai


Session A65 - PULMONARY CLINICAL CASES II

Time: 11:15 AM - 1:15 PM

P51 - Assessing Treatment Response to Endobronchial Valve Therapy Using CT Based Densitometry: A Case Study
R. Baron, S. Kadlecek, H. Hamedani, F. Amzajerdian, Y. Xin, J. Thomas, I. Duncan, M. Ismail, L. Loza, T. Achekzai, M. Cereda, G. J. Criner, R. R. Rizi


Session A91 - MYTHS OR TRUTHS: CONTROVERSIES IN RESPIRATORY MEDICINE

Time: 2:20 PM - 2:28 PM

Truth: Patients With Intermediate Risk Pulmonary Embolism Should Undergo Catheter Directed Therapy
Parth Rali, MD. Temple University, Philadelphia, PA


Session A94 - INNOVATIONS IN COPD MANAGEMENT

Time: 3:05 PM - 3:15 PM

Lobar Perfusion Changes Following Bronchoscopic Lung Volume Reduction
N. Van Der Rijst, S. Gayen, S. Dadparvar, T. Sinha, B. H. Lashari, O. A. O'Corragain, R. Townsend, N. Patlakh, J. Thomas, N. Marchetti, G. J. Criner

Time: 3:15 PM - 3:25 PM

Weight Gain Following Bronchoscopic Lung Volume Reduction
O. A. O'Corragain, R. Townsend, B. Lashari, T. Sinha, N. van der Rijst, G. J. Criner;


Session A102 - ASSESSMENT OF RESPIRATORY PHYSIOLOGY

Time: 2:15 PM – 3:45 PM

207 - Prevalence of Abnormal Spirometry in Ever Smokers with No Known Obstructive Lung Disease
T. Tran, G. L. Kinney, A. P. Comellas, K. F. Hoth, A. K. Baldomero, C. Wilson, M. Strand, D. L. Demeo, N. Putcha, J. E. Hokanson, J. D. Crapo, N. A. Hanania, E. S. Wan, M. T. Dransfield, A. J. Mamary, J. L. Curtis, R. Casaburi, K. Young, V. Kim, B. J. Make, A. A. Diaz, E. K. Silverman, S. P. Bhatt, E. A. Regan, S. Fortis


Session A109 - THE ODYSSEY, NO LONGER A TRAGEDY: THE CONTINUUM OF LUNG CANCER

Time: 2:15 PM - 3:45 PM

309 - The Philadelphia Lung Cancer Learning Community: A City-Wide Approach to Characterizing and Improving Lung Cancer Screening
J. A. Barta, C. P. Erkmen, R. E. Myers, C. S. Shusted, S. Cohen, C. Saia, J. Wainwright, F. Dako, R. Wender, G. C. Kane, A. Vachani, K. A. Rendle

Back to top >

Monday, May 16, 2022

Session B14 - OLD DOGS NEW TRICKS: LATE-BREAKING ABSTRACTS IN OBSTRUCTIVE LUNG DISEASE

Time: 10:20 AM - 10:30 AM

Intervention Study in Overweight Patients with COPD (INSIGHT COPD): A Pulmonary Trials Cooperative Randomized Clinical Trial
D. H. Au, E. Gleason, R. Hunter-Merrill, A. Barón, M. Collins, N. Lv, C. Ronneberg, P. Rise, R. Plumley, S. Wisniewski, F. C. Sciurba, D. Kim, P. F. Simonelli, J. A. Krishnan, C. H. Wendt, L. C. Feemster, G. J. Criner, V. Maddipati, A. Mohan, J. Ma

Time: 11:15 AM - 1:15 PM

P485 - Bronchial Rheoplasty for Chronic Bronchitis: 2 Year Results from a Us Feasibility Study with Rheox®
F. C. Sciurba, A. P. Comellas, A. Majid, D. K. Hogarth, N. Marchetti, V. Kim, M. T. Dransfield

Time: 2:15 PM - 3:45 PM

Clinical Topics in Pulmonary Medicine. B82. CRITICAL CHALLENGES AND COMPELLING QUESTIONS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Chair and Introductory - Victor Kim, MD, ATSF Temple Lung Center, Philadelphia, PA


Session B39 - COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES

Time: 11:15 AM - 1:15 PM

P483 - A Meta-Analysis of Zephyr Endobronchial Valves for Management of Persistent Air Leaks
D. K. Hogarth, A. Wagh, A. K. Mahajan, B. Armstrong, N. S. Shargill, J. M. Travaline, G. J. Criner

P488 - Presence of Collateral of Ventilation in Candidates for Bronchoscopic Lung Volume Reduction with Endobronchial Valves and Fissures Integrity > 80%
G. J. Criner, J. Thomas, N. Patlakh, N. Marchetti

P489 - Final Treatment Assignment of Patients with Severe Emphysema Referred for Bronchoscopic Lung Volume Reduction
G. J. Criner, J. Thomas, N. Patlakh, N. Marchetti

P490 - Relationship of Increase in FEV1 to Reduction in RV Post Bronchoscopic Lung Volume Reduction
N. Marchetti, N. Patlakh, J. Thomas, G. J. Criner

P493 - Effect of Bronchscopic Lung Volume Reduction with Endobronchial Valves on Ipsilateral Non-Treated Lung Structure in Patients with Advanced Emphysema
T. Sinha, B. H. Lashari, N. Van Der Rijst, S. U. Pettigrew, N. Marchetti, G. J. Criner

P494 - Impact of Bronchoscopic Lung Volume Reduction with Total Lobar Occlusion on Body Mass Index
N. Marchetti, P. Nicole, J. Thomas, G. J. Criner


Session B55 - NONTUBERCULOUS MYCOBACTERIA

Time: 11:15 AM - 1:15 PM

P369 - Survival of Lung Transplant Patients Receiving Treatment for Non-Tuberculous Mycobacteria
B. H. Lashari, N. Van Der Rijst, N. Sullivan, K. Shenoy


Session B68 - CURIOUS PRESENTATIONS: CANCERS AND MIMICKERS

Time: 11:15 AM - 1:15 PM

P253 - Unusual Presentation of Pneumonic-Type Lung Adenocarcinoma and Diffuse Air-Space Consolidation
E. S. Randhawa, J. Randhawa, N. Mills


Session B93 - BREAKTHROUGHS IN PEDIATRIC AND ADULT ASTHMA CLINICAL TRIALS

Time: 2:55 PM - 3:05 PM

An Add-on Reliever-Triggered Inhaled Corticosteroid Strategy Reduces Severe Asthma Exacerbations in a Real-World Study of African American/Black and Hispanic/Latinx Patients with Asthma
J. C. Cardet, W. D. Pace, J. K. Carroll, A. L. Fuhlbrigge, L. She, F. W. Rockhold, N. E. Maher, M. Fagan, V. E. Forth, P. Arias Hernandez, J. Kruse, B. K. Manning, J. Rodriguez-Louis, J. B. Shields, B. Ericson, A. D. Colon-Moya, T. Coyne-Beasley, G. M. Hammer, B. M. Kaplan, S. Madison, C. S. Rand, J. Robles, O. Thompson, M. E. Wechsler, J. P. Wisnivesky, M. D. McKee, S. P. Jariwala, E. Jerschow, P. J. Busse, D. C. Kaelber, S. Nazario, M. L. Hernandez, A. J. Apter, K. Chang, V. Pinto-Plata, P. M. Stranges, L. H. Hurley, J. Trevor, T. B. Casale, G. Chupp, I. L. Riley, K. V. Shenoy, M. Pasarica, R. A. Calderon Candelario, H. Tapp, A. Baydur, B. P. Yawn, E. Israel


Session B101 - VARIED OMICS TECHNIQUES APPLIED TO ALLERGIC AND RESPIRATORY TRAITS

Time: 2:15 PM - 3:45 PM

520 - Associations of Serum and Bronchoalveolar Immunoglobulins with Lung Microbiota Diversity, B-Cell memory Phenotypes, and COPD Morbidity and Exacerbations
V. Tejwani, N. Putcha, H. Woo, C. Liu, D. Lafon, M. T. Dransfield, A. P. Comellas, A. Azar, W. K. O'Neal, R. Barr, V. E. Ortega, R. Paine, I. Barjaktarevic, P. Woodruff, R. P. Bowler, F. J. Martinez, S. P. Peters, M. K. Han, J. A. Ohar, J. A. Krishnan, G. J. Criner, N. E. Alexis, M. R. Stampfli, R. J. Kaner, N. N. Hansel, C. M. Freeman, Y. J. Huang, J. L. Curtis


Session B103 - OUTCOMES AND BIOMARKERS IN ILD

Time: 2:15 PM - 3:45 PM

420 - Characteristics of Lung Transplant Recipients with Idiopathic Pulmonary Fibrosis and Moderate or Severe Secondary Pulmonary Hypertension, and Determinants of Post-Transplant Survival
B. H. Lashari, R. J. Vender, Y. Dotan, A. J. Mamary


Session B108 - ORIGINS AND OUTCOMES OF COPD

Time: 2:15 PM - 3:45 PM

102 - Epigenetic Biomarker of Telmetric Age Highlights Sex Differences in Chonic Obstructive Pulmonary Disease Exacerbations
A. I. Hernandez Cordero, C. Yang, S. Milne, V. Y. Chen, Z. Hollander, R. Ng, G. J. Criner, P. Woodruff, S. C. Lazarus, J. E. Connett, M. K. Han, F. J. Martinez, R. M. Reed, S. F. Paul Man, J. M. Leung, D. D. Sin

Back to top >

Tuesday, May 17, 2022

Session C18 - COPD: WHO, WHY, AND HOW

Time: 10:00 AM - 10:10 AM

SPIROMICS COPD Patients with Decline of Lung Function Have Thinner Airway Walls at Baseline and Are More Likely to Show Bronchodilator Responsiveness
D. Gomez Ladron De Guevara, W. H. Anderson, D. Couper, P. M. Quibrera, I. Z. Barjaktarevic, R. Barr, S. P. Bhatt, E. R. Bleecker, R. Bowler, S. Christenson, A. P. Comellas, J. L. Curtis, M. B. Dransfield, S. Fortis, M. K. Han, N. N. Hansel, E. A. Hoffman, R. E. Kanner, V. Kim, J. A. Krishnan, F. J. Martinez, V. E. Ortega, W. K. O’Neal, R. Paine III, S. P. Peters, N. Putcha, S. I. Rennard, B. Smith, D. P. Tashkin, P. G. Woodruff, C. B. Cooper, SPIROMICS Investigators


Session C38 - RARE AND COMMON ILDS: EPIDEMIOLOGY, DIAGNOSIS, AND MANAGEMENT

Time: 11:15 AM - 1:15 PM
 
P349 - Are Low Dose CT Scan Lung Screening Criteria Useful in Lung Transplant Recipients?
B. H. Lashari, R. J. Vender, T. Sinha, D. C. Fleitas Sosa, G. J. Criner
 
P350 - Incidence of Lung Cancer in Lung Transplant Recipients
R. J. Vender, B. H. Lashari, T. Sinha, D. C. Fleitas Sosa, G. J. Criner

P351 - Doubling Time of Primary Lung Cancers in Lung Transplant Patients
S. Dachert, B. H. Lashari, R. J. Vender, M. Kumaran, M. Weir
 
P357 - Post-Transplant Survival in Patients with Idiopathic Pulmonary Fibrosis with Moderate and Severe Pulmonary Hypertension
B. H. Lashari, R. J. Vender, T. Sinha, Y. Dotan, A. J. Mamary


Session C40 - INVESTIGATIONS IN INTERVENTIONAL PULMONOLOGY AND PLEURAL DISEASE

Time: 11:15 AM - 1:15 PM

P391 - Outcomes of Bronchoscopic Lung Volume Reduction (BLVR) with Endobronchial Valves (EBV) in Clinical Practice in Patients with Advanced Emphysema and Severe Hyperinflation
G. J. Criner, J. Thomas, N. Patlakh, C. Dass, M. Kumaran, S. Dadparvar, N. Marchetti


Session B57 - CUTTING EDGE COVID RESEARCH

Time: 11:15 AM - 1:15 PM

P886 - High Interleukin-6 Levels on Admission Predicts In-Hospital Mortality in Overweight and Obese COVID-19 Patients
D. C. Fleitas Sosa, N. Van Der Rijst, T. A. Ho, X. Lu, H. Zhao, S. Peterson, V. Kim, K. V. Shenoy


Session C65 - COPD: PRE-CLINICAL MODELS AND MECHANISMS

Time: 11:15 AM - 1:15 PM

P447 - Type II Pneumocytes Accumulates Hyperacetylated Histone H3.3 in Smokes and Chronic Obstructive Pulmonary Disease Subjects
C. A. Barrero, F. Wang, M. C. Rico, M. L. Florez, B. Kosmider, K. Bahmed, G. J. Criner


Session C67 - COPD: TRANSLATIONAL SCIENCE

Time: 11:15 AM - 1:15 PM

P496 - Extracellular Histone H33 Induced Platelets Activation
C. A. Barrero, M. L. Florez, G. J. Criner, M. Rico
 
P499 - Differential DNA Methylation in Lower Airways Epithelial Cells Associate with Lung Function and CT Scan-Based Lung Structure in SPIROMICS
L. M. Reynolds, C. D. Langefeld, A. C. Bishop, T. D. Howard, E. R. Bleecker, G. A. Hawkins, I. Barjaktarevic, S. P. Bhatt, R. P. Bowler, R. Barr, C. B. Cooper, D. Couper, M. K. Han, N. N. Hansel, R. E. Kanner, V. Kim, F. J. Martinez, W. C. Moore, W. K. O'Neal, R. Paine, S. P. Peters, B. M. Smith, P. Woodruff, E. A. Hoffman, S. Christenson, Y. J. Huang, D. A. Meyers, J. L. Curtis, V. E. Ortega, for the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) Investigators


Session C82 - CHRONIC BRONCHITIS: BIOLOGIC UNDERPINNINGS, CLINICAL IMPLICATIONS AND THERAPEUTIC OPPORTUNITIES

Time: 3:21 PM - 3:36 PM

Inside the Airways: The Potential of Bronchoscopic Interventions in Chronic Bronchitis
Victor Kim, MD, ATSF Temple Lung Center, Philadelphia, PA


Session C101 - EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS

Time: 2:15 PM - 3:45 PM

622 - Single Center Outcomes of Biological Agents for Asthma and Effects on Weight
E. S. Randhawa, J. Randhawa, K. V. Shenoy


Session C103 - IT'S NOT JUST ABOUT IPF

Time: 2:15 PM - 3:45 PM

123 - A Phase 2 Trial of INOpulse in Patients with Sarcoidosis Associated Pulmonary Hypertension (SAPH) Requiring Supplemental Oxygen
E. L. Parsley, R. P. Baughman, J. I. Stewart, S. Aryal, P. P. Fernandes, P. Shah, S. D. Nathan


Session C107 - IMMUNOCOMPROMISED LUNG DISEASE, HIV, AND BEYOND

Time: 2:15 PM - 3:45 PM

207 - Impact of Non-Tuberculous Mycobacterial Infection on Bronchiolitis Obliterans Syndrome and Mortality in Lung Transplant Recipients
B. H. Lashari, N. Van Der Rijst, N. Sullivan, T. Thakur, K. Shenoy

Back to top >

Wednesday, May 18, 2022

Session D14 - EMERGING PREDICTORS OF COPD OUTCOMES

Time: 8:35 AM - 8:45 AM

Airway Mucus Plugs and Mortality in COPD: Findings from the COPDGene Study
A. A. Diaz, S. Grumley, H. P. Nath, W. Wang, A. C. Yen, S. J. Kligerman, M. Abozeed, P. P. Manapragada, M. U. Aziz, K. Jacobs, M. Zahid, W. R. Dolliver, J. Orejas, A. N. Ahmed, N. L. Terry, V. Kim, M. H. Cho, R. San Jose Estepar


Session D22 - ADDRESSING HEALTH DISPARITIES IN LUNG DISEASE

Time:  8:15 AM - 9:45 AM

305 - Sex Differences in Airway Mucus Plugs Among Patients with COPD
J. Orejas, W. R. Dolliver, R. Elalami, A. Tsao, R. San Jose Estepar, S. Grumley, N. Hrudaya, W. Wang, S. J. Kligerman, P. Manapragada, K. Jacobs, A. Yen, M. Abozeed, M. Aziz, Z. Mohd, A. Ahmed, N. Terry, V. Kim, R. San Jose Estepar, M. H. Cho, A. A. Diaz


Session D93 - ADVANCES IN PRE AND POST LUNG TRANSPLANT CARE: FROM SELECTION TO CLAD

Time: 12:55 PM - 1:05 PM

Examining Grouping and Transplant Waitlist Mortality Among Sarcoidosis Patients in the Lung Allocation Score (LAS) Era
S. Gayen, D. C. Fleitas Sosa, M. Zheng, A. J. Gangemi, H. Zhao, S. Sehgal, G. J. Criner, A. J. Mamary, R. Gupta

Time: 1:05 PM - 1:15 PM

Sarcoid versus COPD Lung Transplant Waitlist Mortality in the Lung Allocation Score (LAS) Era, a National Registry Database Study
D. Fleitas Sosa, S. Gayen, M. Zheng, H. Zhao, A. J. Gangemi, S. Sehgal, R. Gupta, A. J. Mamary


Session D106 - NOE VALLEY: CLOTS, COVID, AND LUNG VASCULAR DISEASES

Time: 12:45 PM - 2:15 PM
 
1005 - Lactic Acid in Acute Pulmonary Embolism Can Add to Risk
D. Sacher, O. A. O'Corragain, T. Thakur, R. Badlani, H. Davis, K. Lio, N. Mehta, J. Moore, R. Bashir, V. Lakhter, J. Panaro, G. J. Criner, P. Rali

1008 - A Deeper Dive into Acute Pulmonary Embolism (PE): How Histopathological Features May Better Explain the Wide Range of Clinical Symptoms
V. Upadhyay, S. Gayen, A. Aneja, M. Kumaran, R. Bashir, V. Lakhter, J. Panaro, G. Cohen, G. J. Criner, P. Rali


Session D107 - SHOW US WHAT YOU'VE GOT: INTERESTING CASE REPORTS

Time: 12:45 PM - 2:15 PM

205 - A Rare Case of Aspergillus Empyema Thoracic as a Complication of COVID-19 Pneumonia
V. Williams, M. Diamond, P. Shah